3D visualisation of hepatitis B vaccine in the oral delivery vehicle SBA-15

[1]  V. Botosso,et al.  Dynamics of encapsulated hepatitis B surface antigen , 2019, The European Physical Journal Special Topics.

[2]  C. Carucci,et al.  Significant Enhancement of Structural Stability of the Hyperhalophilic ADH from Haloferax volcanii via Entrapment on Metal Organic Framework Support. , 2018, Langmuir : the ACS journal of surfaces and colloids.

[3]  André Hilger,et al.  CONRAD-2: Cold Neutron Tomography and Radiography at BER II (V7) , 2016 .

[4]  Paulo R. A. F. Garcia,et al.  Nanostructured SBA-15 silica: An effective protective vehicle to oral hepatitis B vaccine immunization. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[5]  W. Jiskoot,et al.  Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[6]  J. Banhart,et al.  CONRAD-2: the new neutron imaging instrument at the Helmholtz-Zentrum Berlin , 2016 .

[7]  Sylvain Bohic,et al.  ID16B: a hard X-ray nanoprobe beamline at the ESRF for nano-analysis , 2016, Journal of synchrotron radiation.

[8]  N. Petrovsky.  Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs , 2015, Drug Safety.

[9]  E. Lavelle,et al.  Delivery strategies to enhance oral vaccination against enteric infections. , 2015, Advanced drug delivery reviews.

[10]  Z. Su,et al.  Aggregation and antigenicity of virus like particle in salt solution--A case study with hepatitis B surface antigen. , 2015, Vaccine.

[11]  S. Gabrielsson,et al.  Mesoporous silica particles potentiate antigen-specific T-cell responses. , 2014, Nanomedicine.

[12]  M. Fantini,et al.  Physical properties of ordered mesoporous SBA-15 silica as immunological adjuvant , 2014 .

[13]  R. Zare,et al.  One-pot synthesis of protein-embedded metal-organic frameworks with enhanced biological activities. , 2014, Nano letters.

[14]  T. Tyliszczak,et al.  Spatially resolved NEXAFS spectroscopy of siderophores in biological matrices , 2013 .

[15]  Eric C. Carnes,et al.  Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. , 2013, Accounts of chemical research.

[16]  S. Gabrielsson,et al.  Adjuvant properties of mesoporous silica particles tune the development of effector T cells. , 2012, Small.

[17]  T. Kumasaka,et al.  Protein encapsulation within synthetic molecular hosts , 2012, Nature Communications.

[18]  C. L. Oliveira.  Investigating Macromolecular Complexes in Solution by Small Angle X-Ray Scattering , 2011 .

[19]  V. Botosso,et al.  Nanostructured SBA-15 silica as an adjuvant in immunizations with hepatitis B vaccine. , 2011, Einstein.

[20]  Shengqian Ma,et al.  Immobilization of MP-11 into a mesoporous metal-organic framework, MP-11@mesoMOF: a new platform for enzymatic catalysis. , 2011, Journal of the American Chemical Society.

[21]  I. Berkower,et al.  Hepatitis B Virus Surface Antigen Assembly Function Persists when Entire Transmembrane Domains 1 and 3 Are Replaced by a Heterologous Transmembrane Sequence , 2010, Journal of Virology.

[22]  D. Tambourgi,et al.  Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15. , 2010, Vaccine.

[23]  U. Frommherz,et al.  Higher Order Suppressor (HOS) for the PolLux microspectroscope beamline at the Swiss Light Source SLS , 2010 .

[24]  Samir Mitragotri,et al.  Macrophages Recognize Size and Shape of Their Targets , 2010, PloS one.

[25]  H. Kiyono,et al.  Mucosal vaccines: novel advances in technology and delivery , 2009, Expert review of vaccines.

[26]  P. Duringer,et al.  Ultrastructural and chemical study of modern and fossil sporoderms by Scanning Transmission X-ray Microscopy (STXM) , 2009 .

[27]  T. Tyliszczak,et al.  PolLux: a new facility for soft x-ray spectromicroscopy at the Swiss Light Source. , 2008, The Review of scientific instruments.

[28]  Robert Langer,et al.  The biocompatibility of mesoporous silicates. , 2008, Biomaterials.

[29]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[30]  H. Ade,et al.  The PolLux Microspectroscopy Beam line at the Swiss Light Source , 2007 .

[31]  David F. Williams.  Biofunctionality and Biocompatibility , 2006 .

[32]  M. Jaroniec,et al.  Ordered mesoporous silica SBA-15: a new effective adjuvant to induce antibody response. , 2006, Small.

[33]  Jan Holmgren,et al.  Mucosal immunity and vaccines , 2005, Nature Medicine.

[34]  H. Gies,et al.  Protein encapsulation in mesoporous silicate: the effects of confinement on protein stability, hydration, and volumetric properties. , 2004, Journal of the American Chemical Society.

[35]  D I Svergun,et al.  Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. , 1999, Biophysical journal.

[36]  Bradley F. Chmelka,et al.  Nonionic Triblock and Star Diblock Copolymer and Oligomeric Surfactant Syntheses of Highly Ordered, Hydrothermally Stable, Mesoporous Silica Structures , 1998 .

[37]  Fredrickson,et al.  Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores , 1998, Science.

[38]  I. D. Morrison,et al.  Improved techniques for particle size determination by quasi-elastic light scattering , 1985 .

[39]  Robyn P. Seipp,et al.  MUCOSAL IMMUNITY AND VACCINES , 2013 .

[40]  M. Levine.  developing countries: lessons from a live cholera vaccine , 2010 .

[41]  Á. Ortega,et al.  Supporting Material : Prediction of hydrodynamic and other solution properties of rigid proteins from atomic and residue-level models , 2022 .